SNHG1 and urinary bladder cancer: Notably, the present study provided evidence that SNHG1 promotes MDM2 expression by binding to miR-9-3p to promote PPARγ ubiquitination and downregulate PPARγ expression, thereby resulting in elevation of bladder cancer cell proliferation in vitro and tumorigenesis in vivo.